Literature DB >> 8938199

Epidemiological data suggest antidepressants reduce suicide risk among depressives.

G Isacsson1, U Bergman, C L Rich.   

Abstract

In spite of the availability of antidepressant medication for several decades, it has not been shown that such medication lowers the risk for suicide in depressed patients. This report explores this apparent paradox by means of pharmacoepidemiological methods. Data on the prevalence of depression in the population and among suicides as well as data on the prevalence of antidepressant medication in depressed suicides were obtained from a review of the literature. Data on the prevalence of antidepressant medication in the population in 1990-1991 were obtained from the statistics of the Swedish National Corporation of Pharmacies. It was found that only one in five depressed individuals with major depression were treated with antidepressants in Sweden. The calculated risk for suicide among depressed patients who were treated with antidepressants was 141 per 100,000 person years and, among the untreated, 259 per 100,000 person years (i.e., 1.8 times higher among the untreated). This supports the hypothesis that antidepressant medication decreases the risk for suicide in depressed patients. The reason this has not been obvious in the general suicide statistics seems to be that so few depressed people are treated with antidepressants. Effective suicide prevention strategies should include intensive efforts to recognize and treat more depressed people.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8938199     DOI: 10.1016/0165-0327(96)00050-x

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  16 in total

Review 1.  Strategies for quantifying the relationship between medications and suicidal behaviour: what has been learned?

Authors:  Robert D Gibbons; J John Mann
Journal:  Drug Saf       Date:  2011-05-01       Impact factor: 5.606

2.  False beliefs: the current treatment of patients with depression.

Authors:  Yves Lecrubier
Journal:  Curr Psychiatry Rep       Date:  2003-12       Impact factor: 5.285

3.  Existing and novel biological therapeutics in suicide prevention.

Authors:  Joshua J Griffiths; Carlos A Zarate; J J Rasimas
Journal:  Am J Prev Med       Date:  2014-09       Impact factor: 5.043

Review 4.  Evidence for beneficial effects of antidepressants on suicidality in depressive patients: a systematic review.

Authors:  Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-06-16       Impact factor: 5.270

5.  Gender differences in suicide methods.

Authors:  Valerie J Callanan; Mark S Davis
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2011-05-22       Impact factor: 4.328

6.  Postmortem Presence of Drugs and Method of Violent Suicide.

Authors:  Connor M Sheehan; Richard G Rogers; Jason D Boardman
Journal:  J Drug Issues       Date:  2015-04-29

7.  Predictors of suicidality in depressive spectrum disorders in the general population: results of the Netherlands Mental Health Survey and Incidence Study.

Authors:  Jan Spijker; Ron de Graaf; Margreet Ten Have; Willem A Nolen; Anne Speckens
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-07-19       Impact factor: 4.328

Review 8.  Advances in the treatment of anxiety: targeting glutamate.

Authors:  Asher B Simon; Jack M Gorman
Journal:  NeuroRx       Date:  2006-01

9.  Association between antidepressant prescribing and suicide in Australia, 1991-2000: trend analysis.

Authors:  Wayne D Hall; Andrea Mant; Philip B Mitchell; Valerie A Rendle; Ian B Hickie; Peter McManus
Journal:  BMJ       Date:  2003-05-10

Review 10.  Post-approval drug safety surveillance.

Authors:  Robert D Gibbons; Anup K Amatya; C Hendricks Brown; Kwan Hur; Sue M Marcus; Dulal K Bhaumik; J John Mann
Journal:  Annu Rev Public Health       Date:  2010       Impact factor: 21.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.